Cargando…

Radiotherapy for primary thyroid adenoid cystic carcinoma

Primary thyroid adenoid cystic carcinoma (PTACC) is an extremely rare type of mucin-secreting adenocarcinoma. Currently, it is difficult to diagnose, and it lacks standard treatment protocols. We report the case of a 53-year-old female patient with PTACC who underwent additional intensity-modulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xiaoyu, Hu, Tingting, Cai, Hongyi, Lin, Lili, Zeng, Lu, Wang, Huixia, Cao, Lei, Li, Xuxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993328/
https://www.ncbi.nlm.nih.gov/pubmed/36910470
http://dx.doi.org/10.1515/biol-2022-0547
_version_ 1784902510790574080
author Duan, Xiaoyu
Hu, Tingting
Cai, Hongyi
Lin, Lili
Zeng, Lu
Wang, Huixia
Cao, Lei
Li, Xuxia
author_facet Duan, Xiaoyu
Hu, Tingting
Cai, Hongyi
Lin, Lili
Zeng, Lu
Wang, Huixia
Cao, Lei
Li, Xuxia
author_sort Duan, Xiaoyu
collection PubMed
description Primary thyroid adenoid cystic carcinoma (PTACC) is an extremely rare type of mucin-secreting adenocarcinoma. Currently, it is difficult to diagnose, and it lacks standard treatment protocols. We report the case of a 53-year-old female patient with PTACC who underwent additional intensity-modulated radiotherapy 1 month after surgical treatment with an uneventful course. No invasion or distant metastasis was detected at the 7-month follow-up after radiotherapy, and the prognosis was favorable. In this case, herein, we have summarized the diagnostic features of the disease and proposed that postoperative adjuvant radiotherapy can significantly improve the patient’s prognosis. Finally, we further confirmed the important role of radiotherapy in PTACC by reviewing relevant literature, which may provide clinicians with valuable treatment experience.
format Online
Article
Text
id pubmed-9993328
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-99933282023-03-09 Radiotherapy for primary thyroid adenoid cystic carcinoma Duan, Xiaoyu Hu, Tingting Cai, Hongyi Lin, Lili Zeng, Lu Wang, Huixia Cao, Lei Li, Xuxia Open Life Sci Case Report Primary thyroid adenoid cystic carcinoma (PTACC) is an extremely rare type of mucin-secreting adenocarcinoma. Currently, it is difficult to diagnose, and it lacks standard treatment protocols. We report the case of a 53-year-old female patient with PTACC who underwent additional intensity-modulated radiotherapy 1 month after surgical treatment with an uneventful course. No invasion or distant metastasis was detected at the 7-month follow-up after radiotherapy, and the prognosis was favorable. In this case, herein, we have summarized the diagnostic features of the disease and proposed that postoperative adjuvant radiotherapy can significantly improve the patient’s prognosis. Finally, we further confirmed the important role of radiotherapy in PTACC by reviewing relevant literature, which may provide clinicians with valuable treatment experience. De Gruyter 2023-03-07 /pmc/articles/PMC9993328/ /pubmed/36910470 http://dx.doi.org/10.1515/biol-2022-0547 Text en © 2023 the author(s), published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Case Report
Duan, Xiaoyu
Hu, Tingting
Cai, Hongyi
Lin, Lili
Zeng, Lu
Wang, Huixia
Cao, Lei
Li, Xuxia
Radiotherapy for primary thyroid adenoid cystic carcinoma
title Radiotherapy for primary thyroid adenoid cystic carcinoma
title_full Radiotherapy for primary thyroid adenoid cystic carcinoma
title_fullStr Radiotherapy for primary thyroid adenoid cystic carcinoma
title_full_unstemmed Radiotherapy for primary thyroid adenoid cystic carcinoma
title_short Radiotherapy for primary thyroid adenoid cystic carcinoma
title_sort radiotherapy for primary thyroid adenoid cystic carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993328/
https://www.ncbi.nlm.nih.gov/pubmed/36910470
http://dx.doi.org/10.1515/biol-2022-0547
work_keys_str_mv AT duanxiaoyu radiotherapyforprimarythyroidadenoidcysticcarcinoma
AT hutingting radiotherapyforprimarythyroidadenoidcysticcarcinoma
AT caihongyi radiotherapyforprimarythyroidadenoidcysticcarcinoma
AT linlili radiotherapyforprimarythyroidadenoidcysticcarcinoma
AT zenglu radiotherapyforprimarythyroidadenoidcysticcarcinoma
AT wanghuixia radiotherapyforprimarythyroidadenoidcysticcarcinoma
AT caolei radiotherapyforprimarythyroidadenoidcysticcarcinoma
AT lixuxia radiotherapyforprimarythyroidadenoidcysticcarcinoma